B. Riley Securities Initiates Coverage On Neuronetics with Buy Rating, Announces Price Target of $5

B. Riley Securities analyst Madison El-Saadi initiates coverage on Neuronetics (NASDAQ:STIM) with a Buy rating and announces Price Target of $5.